Compound Detail
CHEMBL4116008
CERDULATINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4116008 |
| Name | CERDULATINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BGLPECHZZQDNCD-UHFFFAOYSA-N |
23
Targets
47
Activities
2
Assay Types
0
PK Parameters
20
Publications
4
Known Names
5
Indications
4
Mechanisms
Molecular Properties
445.6
MW (Da)
1.37
ALogP
8
HBA
3
HBD
133.6
PSA (Ų)
0.55
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase SYK inhibitor | INHIBITOR | Tyrosine-protein kinase SYK | ✓ | ✓ |
| Tyrosine-protein kinase JAK1 inhibitor | INHIBITOR | Tyrosine-protein kinase JAK1 | ✓ | ✓ |
| Tyrosine-protein kinase JAK3 inhibitor | INHIBITOR | Tyrosine-protein kinase JAK3 | ✓ | ✓ |
| Tyrosine-protein kinase TYK2 inhibitor | INHIBITOR | Non-receptor tyrosine-protein kinase TYK2 | ✓ | ✓ |
Indications
Enteropathy-Associated T-Cell Lymphoma Vitiligo Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Follicular
Activity Summary
IC50 42 meas. best 9.3
Kd 5 meas. best 8.48
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine